HIF HYDROXYLASE INHIBITORS FOR TREATMENT OF ANEMIA OF CANCER
    5.
    发明公开
    HIF HYDROXYLASE INHIBITORS FOR TREATMENT OF ANEMIA OF CANCER 审中-公开
    HIF-羟化酶抑制剂对肿瘤疾病的治疗

    公开(公告)号:EP2035000A1

    公开(公告)日:2009-03-18

    申请号:EP07796204.1

    申请日:2007-06-14

    申请人: FIBROGEN, INC.

    IPC分类号: A61K31/47 A61P7/06

    CPC分类号: A61K31/47

    摘要: The invention relates to methods and compounds for treating anemia of cancer. In particular, methods for treating anemia of cancer in a subject having cancer, and methods for increasing reticulocytes, increasing hemoglobin, increasing hematocrit, and increasing red blood cell count in subjects having anemia of cancer, wherein such subjects are refractory to treatment with recombinant human erythropoietin (EPO) are encompassed herein.

    COMPOUNDS AND METHODS FOR TREATMENT OF STROKE
    9.
    发明公开
    COMPOUNDS AND METHODS FOR TREATMENT OF STROKE 审中-公开
    VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON APOPLEXIE

    公开(公告)号:EP1991269A1

    公开(公告)日:2008-11-19

    申请号:EP07750392.8

    申请日:2007-02-08

    申请人: FIBROGEN, INC.

    IPC分类号: A61K45/00 A61P9/10

    摘要: The present invention relates to methods and agents useful for the treatment of stroke, including ischemic stroke and hemorrhagic stroke. In particular, methods and agents for treating stroke in a subject are provided, wherein the agent is administered prior to diagnosis of the stroke as an ischemic stroke or a hemorrhagic stroke.

    摘要翻译: 本发明涉及可用于治疗中风的方法和药剂,包括缺血性卒中和出血性中风。 特别地,提供了用于治疗受试者中风的方法和药剂,其中所述药物在诊断为中风之前作为缺血性中风或出血性中风进行施用。